clinical trial tirzepatide Tirzepatide: First Approval | Drugs Weight-loss drug tirzepatide may lower

PlexusDx Precision Peptide Genetic Test examines variants in GLP1R, GIPR, FTO, MC4R, and 45 other peptide-related genes across 14 metabolic pathways, revealing your individual predisposition to side effects and treatment response

PMID: 45 Petkovi-DabiJBiniICariBBoiLUmievi-ipkaSBednarukNet al

Garcia-Molina F, Hiner ANP, Fenoll LG, Rodriguez-Lopez JN, Garcia-Ruiz PA, Garcia-Canovas F, et al

This shows confidence in the formula and provides reassurance for new buyers

According to the FDA prescribing information, tirzepatide is not recommended for patients with severe gastrointestinal disease, such as severe gastroparesis